Matthew R. Cooperberg, MD, MPH, Professor of Urology and Epidemiology and Biostatistics at the University of California, San Francisco, argues pre-diagnosis, PSA is one of the best cancer markers ever studied, we just haven’t used it properly. He suggests biomarkers can persuade primary care physicians to increase patient screening of prostate cancer.
